VEGFA and carcinoma: These results confirm those of our previous study, and are of interest in the light of the findings of Nakajima et al (2004), who demonstrated that 2-deoxy-L-ribose, the stereoisomer of TP's product, suppressed the hypoxic expression of VEGF by the carcinoma cell line KB-3-1.